Alphanosos

We leverage our disruptive, Artificial Intelligence (AI) based, proprietary discovery process to discover and patent active ingredients and products based on patentable mixes of plant extracts with a history of safe human consumption to bring new human and animal therapeutic solutions, with a superior efficacy and reduced risks of side effects relative to traditional mono-compound approaches. We concentrate our discovery efforts on the selective elimination of deleterious cells and micro-organisms, including their biofilms, with an initial focus on genuine alternatives to antibiotics and anti-cancer products.